1.         Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By Type

1.3.2        Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product

1.3.3        Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

1.3.4        Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Prostate Cancer

5.1.2        Increasing Demand for Early and Precise Diagnosis of Prostate Cancer

5.2         Market Restraints

5.2.1        Rising Cost Related to the Prostate Cancer Diagnostics and Treatment

5.3         Market Opportunities

5.3.1        Expanding Use of Radiopharmaceuticals in Prostate Cancer

5.4         Future Trends

5.4.1        Rising Research Activities for Development of Innovative Imaging Agents

5.5         Impact Analysis

6.           Prostate Cancer Nuclear Medicine Diagnostics Market– Europe Analysis

6.1         Europe Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis

7.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type

7.1         Overview

7.2         Europe Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)

7.3         SPECT

7.3.1        Overview

7.3.2        SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         PET

7.4.1        Overview

7.4.2        PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product

8.1         Overview

8.2         Europe Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)

8.3         F-18

8.3.1        Overview

8.3.2        F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         C-11

8.4.1        Overview

8.4.2        C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         GA 68 PSMA

8.5.1        Overview

8.5.2        GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

9.1         Overview

9.2         Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis

10.1      Europe: Prostate Cancer Nuclear Medicine Diagnostics Market

10.1.1     Overview

10.1.2     Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

10.1.2.1       Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4       Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.5       Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2       France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       France: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4       France: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.5       France: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3       UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.4       UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.5       UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4       Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3       Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.4       Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.5       Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5       Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1       Overview

10.1.2.5.2       Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3       Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.4       Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.5       Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6       Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1       Overview

10.1.2.6.2       Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3       Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.4       Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.5       Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.        Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      Blue Earth Diagnostics Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      ImaginAb

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Curium

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Jubilant Radiopharma

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      ABX advanced biochemical compounds GmbH

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Telix Pharmaceuticals Ltd.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Novartis AG

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Theragnostics

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Lantheus Medical Imaging, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4.             France: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 20.          Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 21.          Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market

LIST OF FIGURES

Figure 1.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation

Figure 2.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market, By Country

Figure 3.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market Overview

Figure 4.           PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market

Figure 5.           Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Experts Opinion

Figure 8.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        Europe Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)

Figure 11.        Europe SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Europe PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Europe Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)

Figure 14.        Europe F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        Europe C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        Europe GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)

Figure 18.        Europe Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Europe Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Europe Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 22.        Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 23.        Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028